Tag Archives: ADA 2025 guidelines

Obesity is no longer just a lifestyle issue — it’s now globally recognized as a chronic, relapsing disease. In a bold move, the World Health Organization (WHO) has formally endorsed GLP‑1 therapy obesity treatments for long-term management in adults. This policy shift holds significant implications for diabetes care, especially as …

Read More »